Connection

TAO SHEN to Sirolimus

This is a "connection" page, showing publications TAO SHEN has written about Sirolimus.
Connection Strength

0.242
  1. Rapamycin inhibits lymphatic endothelial cell tube formation by downregulating vascular endothelial growth factor receptor 3 protein expression. Neoplasia. 2012 Mar; 14(3):228-37.
    View in: PubMed
    Score: 0.087
  2. Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity. J Biol Chem. 2010 Dec 03; 285(49):38362-73.
    View in: PubMed
    Score: 0.079
  3. Rapamycin inhibits IGF-1 stimulated cell motility through PP2A pathway. PLoS One. 2010 May 11; 5(5):e10578.
    View in: PubMed
    Score: 0.076
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.